Liu L, Yu K, Yu J, Tao W, Wei Y
Cytotechnology. 2024; 76(6):833-846.
PMID: 39435426
PMC: 11490624.
DOI: 10.1007/s10616-024-00656-9.
Capasso G, Mouawad N, Castronuovo M, Ruggeri E, Visentin A, Trentin L
Front Oncol. 2024; 14:1446723.
PMID: 39281374
PMC: 11392731.
DOI: 10.3389/fonc.2024.1446723.
Klement L, Drube J
Front Oncol. 2023; 13:1258679.
PMID: 37849810
PMC: 10577206.
DOI: 10.3389/fonc.2023.1258679.
Wang F, Jiang Y, Wang L, Chen Y, Zhang Y, Ma M
Nanomaterials (Basel). 2022; 12(10).
PMID: 35630929
PMC: 9142899.
DOI: 10.3390/nano12101711.
Kong F, He H, Bai H, Yang F, Ma M, Gu N
Bioact Mater. 2022; 18:526-538.
PMID: 35415298
PMC: 8976099.
DOI: 10.1016/j.bioactmat.2022.03.022.
Novel Polyethylene Glycol-Conjugated Triazole Derivative with High Thyrointegrin αvβ3 Affinity in Acute Myeloid Leukemia Management.
Sudha T, Godugu K, Darwish N, Nazeer T, Mousa S
Cancers (Basel). 2021; 13(16).
PMID: 34439224
PMC: 8392871.
DOI: 10.3390/cancers13164070.
Leukemia stem cell-bone marrow microenvironment interplay in acute myeloid leukemia development.
Yao Y, Li F, Huang J, Jin J, Wang H
Exp Hematol Oncol. 2021; 10(1):39.
PMID: 34246314
PMC: 8272391.
DOI: 10.1186/s40164-021-00233-2.
Serum levels of FAK and some of its effectors in adult AML: correlation with prognostic factors and survival.
El-Sisi M, Radwan S, Saeed A, El-Mesallamy H
Mol Cell Biochem. 2021; 476(5):1949-1963.
PMID: 33507464
DOI: 10.1007/s11010-020-04030-z.
Targeting CXCR4 in AML and ALL.
Cancilla D, Rettig M, Dipersio J
Front Oncol. 2020; 10:1672.
PMID: 33014834
PMC: 7499473.
DOI: 10.3389/fonc.2020.01672.
Integrin α7 and Extracellular Matrix Laminin 211 Interaction Promotes Proliferation of Acute Myeloid Leukemia Cells and Is Associated with Granulocytic Sarcoma.
Kobayashi N, Oda T, Takizawa M, Ishizaki T, Tsukamoto N, Yokohama A
Cancers (Basel). 2020; 12(2).
PMID: 32033262
PMC: 7072541.
DOI: 10.3390/cancers12020363.
Prognostic significance of CXCR4 expression in acute myeloid leukemia.
Du W, Lu C, Zhu X, Hu D, Chen X, Li J
Cancer Med. 2019; 8(15):6595-6603.
PMID: 31518054
PMC: 6825984.
DOI: 10.1002/cam4.2535.
Moving Myeloid Leukemia Drug Discovery Into the Third Dimension.
Cartledge Wolf D, Langhans S
Front Pediatr. 2019; 7:314.
PMID: 31417884
PMC: 6682595.
DOI: 10.3389/fped.2019.00314.
Adhesion Deregulation in Acute Myeloid Leukaemia.
Gruszka A, Valli D, Restelli C, Alcalay M
Cells. 2019; 8(1).
PMID: 30658474
PMC: 6356639.
DOI: 10.3390/cells8010066.
Focal Adhesion Genes Refine the Intermediate-Risk Cytogenetic Classification of Acute Myeloid Leukemia.
Pallares V, Hoyos M, Chillon M, Barragan E, Prieto Conde M, Llop M
Cancers (Basel). 2018; 10(11).
PMID: 30428571
PMC: 6265715.
DOI: 10.3390/cancers10110436.
The Possible Importance of β3 Integrins for Leukemogenesis and Chemoresistance in Acute Myeloid Leukemia.
Johansen S, Brenner A, Bartaula-Brevik S, Reikvam H, Bruserud O
Int J Mol Sci. 2018; 19(1).
PMID: 29342970
PMC: 5796198.
DOI: 10.3390/ijms19010251.
, an independent good prognostic factor in intermediate-risk acute myeloid leukemia patients.
Pallares V, Hoyos M, Chillon M, Barragan E, Prieto Conde M, Llop M
Oncotarget. 2017; 8(44):76003-76014.
PMID: 29100287
PMC: 5652681.
DOI: 10.18632/oncotarget.18537.
Focal Adhesion Kinase as a Potential Target in AML and MDS.
Carter B, Mak P, Wang X, Yang H, Garcia-Manero G, Mak D
Mol Cancer Ther. 2017; 16(6):1133-1144.
PMID: 28270436
PMC: 5457713.
DOI: 10.1158/1535-7163.MCT-16-0719.
β-Arrestin1 and Signal-transducing Adaptor Molecule 1 (STAM1) Cooperate to Promote Focal Adhesion Kinase Autophosphorylation and Chemotaxis via the Chemokine Receptor CXCR4.
Alekhina O, Marchese A
J Biol Chem. 2016; 291(50):26083-26097.
PMID: 27789711
PMC: 5207078.
DOI: 10.1074/jbc.M116.757138.
Targeted positron emission tomography imaging of CXCR4 expression in patients with acute myeloid leukemia.
Herhaus P, Habringer S, Philipp-Abbrederis K, Vag T, Gerngross C, Schottelius M
Haematologica. 2016; 101(8):932-40.
PMID: 27175029
PMC: 4967572.
DOI: 10.3324/haematol.2016.142976.
Inhibition of CXCR4 by LY2624587, a Fully Humanized Anti-CXCR4 Antibody Induces Apoptosis of Hematologic Malignancies.
Peng S, Zhang X, Paul D, Kays L, Ye M, Vaillancourt P
PLoS One. 2016; 11(3):e0150585.
PMID: 26954567
PMC: 4782998.
DOI: 10.1371/journal.pone.0150585.